LUISA INDIVIGLIO: Open Payments
NPI 1578006060 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 17 payments from 7 companies in 2025. Trend: 2023 $420 · 2024 $665 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $92 |
| GENZYME CORPORATION | 3 | $89 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $64 |
| CSL Behring | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| BioCryst US Sales Co., LLC | 2 | $45 |
| Amgen Inc. | 1 | $19 |
Products named: Kerendia, DUPIXENT, NEFFY, NUCALA, ORLADEYO, Andembry, Haegarda, OTEZLA.
Industry payments across FL — which companies pay providers there.
